Age-induced augmentation of p38 MAPK phosphorylation in mouse lung

The p38 mitogen-activated protein kinase (p38 MAPK) pathway is a key regulator of pro-inflammatory cytokine biosynthesis, which may contribute to the chronic low-grade inflammation observed with aging. We hypothesize that aging up-regulates the activation of p38 MAPK as well as the pro-inflammatory cytokines tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) in mouse lung, and is accompanied by disturbances in oxidant-antioxidant status. In addition, the elevated protein levels of phosphorylated active form of p38 MAPK (phospho-p38 MAPK) with age are tissue-specific. To test this hypothesis, protein levels of phospho-p38 MAPK were determined using Western blot analysis in isolated lung, brain, heart, spleen, kidney and muscle of young (2-month-old) and aged (20-month-old) male C57BL/6J mice. Results show that phospho-p38 MAPK protein levels, not total-p38 MAPK, increased significantly (p<0.01, n=8) in lung and brain of 20-month-old mice. The activation of p38 MAPK in other tissues was not altered with age. Immunostaining showed that epithelial cells and alveolar macrophages in lung parenchyma were the major cellular sources of phospho-p38 MAPK immunity. As measured by enzyme-linked immunosorbent assay (ELISA), TNF-α, IL-1β and IL-6 in lung homogenates were elevated significantly with age, but there were no differences with age in serum levels except for IL-6. In addition, IL-1β and IL-6 were increased notably while TNF-α was not different with age in bronchoalveolar lavage fluid (BALF). Furthermore, the oxidant-antioxidant status was evaluated by measuring pro-oxidant malondialdehyde (MDA) levels and the activity of reactive oxygen species scavenging enzymes (i.e. superoxide dismutase (SOD) and glutathione (GSH)) in lung homogenates. The results showed that SOD and GSH decreased with age, while MDA did not change. In conclusion, our data demonstrate that p38 MAPK is activated during lung aging with a corresponding increase in pro-inflammatory cytokines and decrease in antioxidant capacity.

[1]  P. Paré,et al.  Associations of IL6 polymorphisms with lung function decline and COPD , 2009, Thorax.

[2]  M. Hosokawa,et al.  Age-related changes in lung structure and function in the senescence-accelerated mouse (SAM): SAM-P/1 as a new murine model of senile hyperinflation of lung. , 1994, American journal of respiratory and critical care medicine.

[3]  A. Lewiński,et al.  The role of oxidative stress in physiological and pathological processes in the thyroid gland; possible involvement in pineal-thyroid interactions. , 2003, Neuro endocrinology letters.

[4]  Junfa Li,et al.  Decreased phosphorylation and protein expression of ERK1/2 in the brain of hypoxic preconditioned mice , 2006, Neuroscience Letters.

[5]  D. Jollow,et al.  Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. , 1974, Pharmacology.

[6]  C. Bradham,et al.  p38 MAPK in Development and Cancer , 2006, Cell cycle.

[7]  S. Kumar,et al.  SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes. , 1998, Journal of immunology.

[8]  M. De la Fuente,et al.  An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. , 2009, Current pharmaceutical design.

[9]  A. Langheinrich,et al.  Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression , 2010, Basic Research in Cardiology.

[10]  P N Viswanathan,et al.  A modified spectrophotometric assay of superoxide dismutase. , 1984, Indian journal of biochemistry & biophysics.

[11]  L. Koenderman,et al.  Systemic inflammation in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[12]  Keisuke Ito,et al.  Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells , 2006, Nature Medicine.

[13]  T. Finkel,et al.  Stem cell aging: what bleach can teach , 2006, Nature Medicine.

[14]  T. Bates,et al.  p38 Mitogen-Activated Protein Kinase Controls NF-κB Transcriptional Activation and Tumor Necrosis Factor Alpha Production through RelA Phosphorylation Mediated by Mitogen- and Stress-Activated Protein Kinase 1 in Response to Borrelia burgdorferi Antigens , 2006, Infection and Immunity.

[15]  Z. Ungvari,et al.  Aging‐induced proinflammatory shift in cytokine expression profile in rat coronary arteries , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  K. Yagi,et al.  A simple fluorometric assay for lipoperoxide in blood plasma. , 1976, Biochemical medicine.

[17]  John C. Lee,et al.  p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. , 1997, Biochemical and biophysical research communications.

[18]  J. Aubry,et al.  Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. , 1999, European journal of biochemistry.

[19]  Sunil K. Kakarla,et al.  Acetaminophen prevents aging‐associated hyperglycemia in aged rats: effect of aging‐associated hyperactivation of p38‐MAPK and ERK1/2 , 2009, Diabetes/metabolism research and reviews.

[20]  P. Bender,et al.  Cell autonomous expression of inflammatory genes in biologically aged fibroblasts associated with elevated NF-kappaB activity , 2008, Immunity & Ageing.

[21]  Jiahuai Han,et al.  Evidence that age‐related changes in p38 MAP kinase contribute to the decreased steroid production by the adrenocortical cells from old rats , 2008, Aging cell.

[22]  H. Krum,et al.  p38 MAP kinase as a therapeutic target in cardiovascular disease , 2004 .

[23]  A. Sun,et al.  P38 MAP kinase is activated at early stages in Alzheimer’s disease brain , 2003, Experimental Neurology.

[24]  G. Johnson,et al.  The p38 MAP kinase signaling pathway in Alzheimer’s disease , 2003, Experimental Neurology.

[25]  G. Kollias,et al.  Generation and Characterization of p38β (MAPK11) Gene-Targeted Mice , 2005, Molecular and Cellular Biology.

[26]  L. Klotz,et al.  Activation pattern of mitogen‐activated protein kinases elicited by peroxynitrite: attenuation by selenite supplementation , 1999, FEBS letters.

[27]  S. Teramoto,et al.  A novel model of senile lung: senescence-accelerated mouse (SAM). , 1994, American journal of respiratory and critical care medicine.

[28]  L. Fabbri,et al.  Increased activation of p38 MAPK in COPD , 2008, European Respiratory Journal.

[29]  N. Rosenthal,et al.  Neutrophils and low-grade inflammation in the seemingly normal aging human lung , 1998, Mechanisms of Ageing and Development.

[30]  K. Aoshiba,et al.  Chronic lung inflammation in aging mice , 2007, FEBS letters.

[31]  S. Anton,et al.  Molecular inflammation: Underpinnings of aging and age-related diseases , 2009, Ageing Research Reviews.

[32]  N. Holbrook,et al.  Oxidants, oxidative stress and the biology of ageing , 2000, Nature.

[33]  G. Firestein,et al.  Signal transduction in rheumatoid arthritis , 2004, Current opinion in rheumatology.

[34]  D. Templeton,et al.  Induction of Cyclooxygenase-2 by the Activated MEKK1 → SEK1/MKK4 → p38 Mitogen-activated Protein Kinase Pathway* , 1998, The Journal of Biological Chemistry.

[35]  Devanand Sarkar,et al.  Molecular mechanisms of aging-associated inflammation. , 2006, Cancer letters.

[36]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[37]  E. Rovida,et al.  p38 and cancer: Yang gets yin , 2008, Cancer biology & therapy.

[38]  S. Castiglioni,et al.  Iterleukin 1 alpha is a marker of endothelial cellular senescent , 2006, Immunity & Ageing.

[39]  P. Clarkson,et al.  Antioxidants and physical performance. , 1995, Critical reviews in food science and nutrition.

[40]  Richard Rabold,et al.  Age-dependent changes of airway and lung parenchyma in C57BL/6J mice. , 2007, Journal of applied physiology.

[41]  Qingbo Xu,et al.  Activation of Mitogen-activated Protein Kinase by HO , 1996, The Journal of Biological Chemistry.

[42]  D. Harman.  Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.

[43]  C. Caruso,et al.  Inflammatory networks in ageing, age-related diseases and longevity , 2007, Mechanisms of Ageing and Development.

[44]  T. Uehara,et al.  Changes in expressions of proinflammatory cytokines IL-1β, TNF-α and IL-6 in the brain of senescence accelerated mouse (SAM) P8 , 2000, Brain Research.

[45]  C. Hsieh,et al.  Thioredoxin‐ASK1 complex levels regulate ROS‐mediated p38 MAPK pathway activity in livers of aged and long‐lived Snell dwarf mice , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  Yasunori Sato,et al.  Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: A culture study , 2008, Free radical research.

[47]  J. Tichelaar,et al.  Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. , 2005, American journal of respiratory cell and molecular biology.

[48]  H. Chung,et al.  Influence of aging and calorie restriction on MAPKs activity in rat kidney , 2002, Experimental Gerontology.

[49]  E. Bröcker,et al.  Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. , 2001, Blood.

[50]  Christopher J. Jones,et al.  Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[51]  Hyoung-Gon Lee,et al.  Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s disease , 2010, Journal of neurochemistry.

[52]  T. Suuronen,et al.  Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging , 2008, Ageing Research Reviews.

[53]  H. Lander,et al.  Differential Activation of Mitogen-activated Protein Kinases by Nitric Oxide-related Species* , 1996, The Journal of Biological Chemistry.

[54]  I. Adcock,et al.  Oxidative stress and redox regulation of lung inflammation in COPD , 2006, European Respiratory Journal.

[55]  A. Lindberg,et al.  Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. , 2005, Chest.

[56]  J. Pincemail,et al.  Oxidative stress in clinical situations--fact or fiction? , 1996, European journal of anaesthesiology.

[57]  M. Fujita,et al.  Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[58]  T. Uehara,et al.  Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. , 2000, Brain research.